Borres, Julia P.

HRN: 20-43-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2025
OXACILLIN 500MG (VIAL)
06/30/2025
07/07/2025
IV
375mg
Q6h
Cellulitis, Left Leg
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines